These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28335657)

  • 1. Molecular characteristics of uterine sarcomas.
    Davidson B; Micci F
    Expert Rev Mol Diagn; 2017 May; 17(5):515-522. PubMed ID: 28335657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures.
    Ravid Y; Formanski M; Smith Y; Reich R; Davidson B
    Gynecol Oncol; 2016 Mar; 140(3):512-7. PubMed ID: 26768834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
    Rommel B; Holzmann C; Bullerdiek J
    Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma.
    Micci F; Heim S; Panagopoulos I
    Genes Chromosomes Cancer; 2021 Mar; 60(3):160-167. PubMed ID: 33099834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
    Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
    Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
    Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.
    Hoang L; Chiang S; Lee CH
    Pathology; 2018 Feb; 50(2):162-177. PubMed ID: 29275929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIT protein expression in uterine sarcomas: an immunohistochemical study and review of the literature.
    Zafrakas M; Theodoridis TD; Zepiridis L; Venizelos ID; Agorastos T; Bontis J
    Eur J Gynaecol Oncol; 2008; 29(3):264-6. PubMed ID: 18592792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
    Alkanat NE; Uner A; Usubutun A
    Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
    [No Abstract]   [Full Text] [Related]  

  • 12. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus.
    Wang L; Felix JC; Lee JL; Tan PY; Tourgeman DE; O'Meara AT; Amezcua CA
    Gynecol Oncol; 2003 Aug; 90(2):402-6. PubMed ID: 12893208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
    Busca A; Parra-Herran C
    Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
    Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
    Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
    Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
    Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategies.
    Hrzenjak A; Dieber-Rotheneder M; Moinfar F; Petru E; Zatloukal K
    Cancer Lett; 2014 Nov; 354(1):21-7. PubMed ID: 25128649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
    Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
    J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine mesenchymal tumours: recent advances.
    Momeni-Boroujeni A; Chiang S
    Histopathology; 2020 Jan; 76(1):64-75. PubMed ID: 31846533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERBB-2 gene overexpression and amplification in uterine sarcomas.
    Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.